MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
Clinical trial NCT06367374 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06367374
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2030-02-28
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.